ID
38343
Description
Study ID: 111539 Clinical Study ID: 111539 Study Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of scalating Repeat Doses of GSK249320 in Patients With Stroke Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00833989 https://clinicaltrials.gov/ct2/show/NCT00833989 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Refanezumab, Placebo Trade Name: N/A Study Indication: Ischaemic Attack, Transient The study consists of 8 visits: Day 1, Week 1 (Day 5), Week 2 (Day 10), Week 4 (Day 30), Week 8 (Day 60), Week 12 (Day 90), Week 16 (Day 112), Follow-up (F/U). All subjects will receive two doses. The first dose within 24-72 hrs after stroke the second dose 9 +/- 1 days after the first one. Each dose will be given as an intravenous infusion over 60 minutes. This document contains the Investigational Product - IV Dosing and the Randomisation form. It has to be filled in for Day 1 and Week 2.
Link
https://clinicaltrials.gov/ct2/show/NCT00833989
Keywords
Versions (2)
- 9/25/19 9/25/19 -
- 10/11/19 10/11/19 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
October 11, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety, Pharmacokinetics and Pharmacodynamics of Refanezumab in Patients with Stroke, NCT00833989
Investigational Product Dosing, Randomisation
- StudyEvent: ODM
Description
Randomisation
Alias
- UMLS CUI-1
- C0034656
Description
If you tick yes, please fill in the Number and the Date of Randomisation in the following items.
Data type
text
Alias
- UMLS CUI [1]
- C0034656
Description
Randomisation number
Data type
integer
Alias
- UMLS CUI [1,1]
- C0034656
- UMLS CUI [1,2]
- C0237753
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C0034656
- UMLS CUI [1,2]
- C0011008
Description
Investigational Product - IV Dosing
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0178602
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0304229
Description
00:00-23:59 Time is optional
Data type
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0304229
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0304229
Description
00:00-23:59 Time is optional
Data type
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0304229
Description
Investigational product container number
Data type
integer
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0180098
- UMLS CUI [1,3]
- C0600091
Description
If you tick yes, please select appropriate reason in the following item.
Data type
text
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1512900
Description
Reason for dose interruption
Data type
integer
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1512900
- UMLS CUI [1,3]
- C0566251
Description
Other reason for dose interruption, specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1512900
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C0566251
- UMLS CUI [1,5]
- C2348235
Description
Total volume of infusion
Data type
float
Measurement units
- ml
Alias
- UMLS CUI [1,1]
- C0574032
- UMLS CUI [1,2]
- C2700258
Similar models
Investigational Product Dosing, Randomisation
- StudyEvent: ODM
C0237753 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0178602 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C1512900 (UMLS CUI [1,2])
C1512900 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C1512900 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C2700258 (UMLS CUI [1,2])